Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/31/2025

Evaluation of Head Injury in Anticoagulated Patients

Immediate Imaging and Risk Stratification

  • The American College of Emergency Physicians recommends that all patients on anticoagulants or antiplatelet agents who sustain head trauma require immediate non-contrast head CT, regardless of mechanism severity or presence of symptoms 1
  • Anticoagulated patients have a 2.6-fold increased risk of significant intracranial injury (3.9% vs 1.5% in non-anticoagulated patients) 1, 2
  • Warfarin carries the highest risk at 10.2% for intracranial hemorrhage, while NOACs carry a 2.6% risk 2
  • Patients on warfarin alone have a relative risk of 1.88 for significant intracranial injury 1
  • Combined aspirin and clopidogrel therapy carries the highest risk with a relative risk of 2.88 1
  • Aspirin monotherapy does not significantly increase risk (relative risk 1.29, 95% CI 0.88-1.87) and is not considered a factor requiring mandatory imaging by itself 1

Management of Intracranial Hemorrhage

  • Immediately discontinue anticoagulation in patients with intracranial hemorrhage 3, 2
  • Obtain immediate neurosurgical consultation in patients with intracranial hemorrhage 3
  • Reverse anticoagulation urgently using 4-factor prothrombin complex concentrate (4F-PCC) plus 5mg IV vitamin K for warfarin, andexanet alfa for apixaban/rivaroxaban, and idarucizumab for dabigatran 3, 2
  • Administer tranexamic acid 1g IV over 10 minutes if within 3 hours of injury (reduces head injury-related death, risk ratio 0.78) 3, 2
  • Obtain repeat head CT within 24 hours, as anticoagulated patients have a 3-fold increased risk of hemorrhage expansion (26% vs 9%) 3, 4, 2

Discharge Criteria and Management

  • Patients with negative initial CT can be safely discharged without repeat imaging or observation if they are neurologically intact, have a Glasgow Coma Scale score of 15, and have no loss of consciousness or post-traumatic amnesia 5, 4
  • The risk of delayed intracranial hemorrhage requiring intervention after negative initial CT is extremely low (<1%) in neurologically intact patients 5, 4
  • Do not routinely discontinue anticoagulation or antiplatelet medications after negative initial CT in neurologically intact patients, as thromboembolic risk may outweigh the small risk of delayed hemorrhage 4, 2

Special Populations and Discharge Instructions

  • Consider brief observation (4-6 hours) if age >80 years with loss of consciousness or amnesia 4
  • Provide written discharge instructions including warning signs requiring immediate return, arrangement for responsible adult observation, and outpatient follow-up for fall risk assessment and reassessment of anticoagulation risk/benefit ratio 4, 2, 3

Evidence‑Based Management of Warfarin‑Associated Traumatic Intracranial Hemorrhage in Elderly Patients

Laboratory Assessment

  • The level of coagulopathy, as measured by the INR, is directly correlated with the risk of bleeding and should be used to guide the choice and urgency of reversal therapy. 6

Reversal Protocol

  • 4‑factor prothrombin complex concentrate (4F‑PCC) is recommended as the first‑line reversal agent for warfarin‑related intracranial hemorrhage, with a strong recommendation over fresh frozen plasma (FFP). 7
  • Concurrent administration of 5 mg intravenous vitamin K is advised to sustain INR normalization after PCC infusion. 8
  • If 4F‑PCC is unavailable, FFP may be used, but this is a strong recommendation only when PCC cannot be obtained, based on moderate‑quality evidence. 7
  • Recombinant factor VIIa should not be used as a first‑line reversal agent for warfarin‑associated intracranial bleeding. 7

Anticoagulation Decision‑Making After a Negative Initial CT

  • In patients who remain neurologically intact after a ground‑level fall and have a negative head CT, the decision to continue or discontinue warfarin must balance the indication for anticoagulation (e.g., atrial fibrillation, mechanical valve, prior thromboembolism) against the individual’s fall risk. 9

REFERENCES

2

Management of Head Injury in Patients on Anticoagulants and Chemotherapy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Management of Intracranial Hemorrhage in Patients on Anticoagulants [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Imaging Guidelines for Patients on Apixaban Anticoagulation with Head Trauma [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026